Labcorp Holdings Inc. (LON:0JSY)
Market Cap | 17.07B |
Revenue (ttm) | 9.84B |
Net Income (ttm) | 557.21M |
Shares Out | n/a |
EPS (ttm) | 6.62 |
PE Ratio | 30.64 |
Forward PE | 16.50 |
Dividend | 2.23 (0.80%) |
Ex-Dividend Date | May 29, 2025 |
Volume | 3 |
Average Volume | 515 |
Open | 278.29 |
Previous Close | 275.67 |
Day's Range | 278.04 - 278.90 |
52-Week Range | 212.91 - 284.40 |
Beta | 0.76 |
RSI | 70.27 |
Earnings Date | Oct 23, 2025 |
About Labcorp Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target... [Read more]
Financial Performance
In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.
Financial numbers in USD Financial StatementsNews
How Do Investors Really Feel About Labcorp Hldgs?
Labcorp Hldgs's (NYSE: LH) short percent of float has fallen 18.87% since its last report. The company recently reported that it has 2.75 million shares sold short , which is 4.3% of all regular shar...
Here's How Much $100 Invested In Labcorp Hldgs 20 Years Ago Would Be Worth Today
Labcorp Hldgs (NYSE: LH) has outperformed the market over the past 20 years by 1.16% on an annualized basis producing an average annual return of 9.85%. Currently, Labcorp Hldgs has a market capitali...
Labcorp launches FDA-cleared blood test for Alzheimer's disease

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C. , Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...
Is the Market Bullish or Bearish on Labcorp Hldgs?
Labcorp Hldgs's (NYSE: LH) short percent of float has fallen 3.99% since its last report. The company recently reported that it has 3.37 million shares sold short , which is 5.3% of all regular share...

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search Developed in collaboration with Amazon Web Services, Test Finder i...

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU BURLINGTON, N.C. , July 29, 2025 /PRNewswire/ -- Lab...

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings
Labcorp Holdings Inc. (NYSE: LH) on Thursday reported stronger-than-expected results for the second quarter . The company posted second-quarter 2025 adjusted earnings per share of $4.35, up from $3.9...

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings
Labcorp Holdings Inc. LH on Thursday reported stronger-than-expected results for the second quarter.

Labcorp Posts 9.5 Percent Gain in Q2
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Why Is Testing Giant Labcorp Stock Surging On Thursday?
Laboratory Corp (NYSE: LH) on Thursday reported second-quarter 2025 adjusted earnings per share of $4.35, up from $3.94 a year ago, beating the consensus of $4.17 . Sales increased 9.5% year-over-year...

Why Is Testing Giant Labcorp Stock Surging On Thursday?
Laboratory Corp (NYSE: LH) on Thursday reported second-quarter 2025 adjusted earnings per share of $4.35, up from $3.94 a year ago, beating the consensus of $4.17.

Labcorp (LH) Q2 2025 Earnings Call Transcript

Labcorp raises annual profit forecast on strong diagnostic testing demand
Labcorp raised its annual profit forecast on Thursday after beating Wall Street estimates for second-quarter profit and revenue on robust demand for its diagnostic tests.

Labcorp Announces 2025 Second Quarter Results
Raises Full-Year Guidance Financial results from Operations for second quarter 2025 versus second quarter 2024: Revenue: $3.53 billion versus $3.22 billion Diluted EPS: $2.84 versus $2.43 Adjusted EPS...
Earnings Scheduled For July 24, 2025
Companies Reporting Before The Bell • Deutsche Bank (NYSE: DB) is likely to report quarterly earnings at $0.78 per share on revenue of $8.82 billion. • TotalEnergies (NYSE: TTE) is likely to report ...

A Glimpse of Laboratory Corp's Earnings Potential
Laboratory Corp (NYSE: LH) is preparing to release its quarterly earnings on Thursday, 2025-07-24. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expe...
Community Health Systems announces agreement to sell select outreach laboratory assets to Labcorp

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp
FRANKLIN, Tenn. & BURLINGTON, N.C.--(BUSINESS WIRE)--Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered int...

My Favorite Options Trade For This Week
Seasonality suggests that markets will fade ahead through August and September before rising again. Knowing this, it’s an excellent time to start looking for bearish trades. One company in particular ...

Labcorp (LH) Stock Signal: Can the Selloff Continue? - 16 July 2025
Declining profit margins and value destruction meet employee warnings over the quality of work. Rising challenges in the US healthcare system could derail profits. Is there more downside ahead for Lab...

Labcorp Declares Quarterly Dividend
BURLINGTON, N.C. , July 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has ...

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low
In my follow-up article on Labcorp, I am upgrading it to a 'Buy' this time. Macro forecasts and the firm's own portfolio growth of solutions and locations could drive more tailwinds to the top line. L...

Labcorp to Announce Second Quarter Financial Results on July 24, 2025
BURLINGTON, N.C. , June 26, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the secon...